Clinical Trial

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Name: Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma — clinical trial record (NCT04437329)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To compare the effectiveness and toxicity of nedaplatin versus cisplatin in induction chemotherapy combined with concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2020-06-17; most recent amendment 2022-05-06.

Trial Details

NCT Number	NCT04437329
Lead Sponsor	Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Conditions	Nasopharyngeal Carcinoma
Enrollment	352 participants
Start Date	2020-08-01
Primary Completion	2028-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2022-05-10